Get complete information related to latest Vacutainer Needle Tenders . from India at Classic Tenders. Search the best available tenders from Indian government tenders, domestic Vacutainer Needle Tenders , private tenders, online tenders, tender invitation notice, business tender notices, online tenders and bidding Vacutainer Needle Tenders.
Tender For srphc82281240-coronary drug eluting stents with (1) stent on cobalt chromium alloy or platinum chromium alloy. (2) stent with coating of polymer carrier for active drug ( sirolimus, everolimus or zotarolimus shown to be effective in preventing neo-intimal hyperplasia) (3) stent diameter should be from 2.5mm to 4mm and length of the stent should be 12mm to 48mm. (4) the strut thickness should be 91 micron or less. (5) stent delivery system should be monorail (single operator exchange or rapid exchange). (6) stent should be compatible with 5fr guiding catheter (7) stent design should be open cell type. (8) stent should be approved by dcgi. the copy of dcgi approval shouldbe enclosed in the tender bid. (9) the long term efficacy and safety of the stent in terms of target vessel revascularisation (tvr) and in-situ thrombosis (ist) should be documented / published in peer reviewed scientific journals. (10) the documents related to the efficacy and safety of the stent should be only for the brand that is offered in the tender bid (11) the manufacturer/supplier should submit proof of supply of the stent toa major government institute.[quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ]
Tender For supply of triple-lumen central venous cannula/catheter set. specification - 1) material: radio opaque biocompatible polyurethane. 2) number of lumen: 3 (three). 3) size: 7f. 4) length of catheter: 16-20 cm. 5) the complete sterile set must contain the following - a) valve needle. b) luer lock syringe 5 ml. c) kink proof guidewire of compatible size and length made of nickel-titanium. d) triple lumen 16g-18g-18g radiopaque-biocompatible-polyurethane made, 7f outer diameter, soft tip, with valves. length marking must be present to assess depth. colour coded lock fittings and lumens. fixation wing at channel junction for cutaneous fixation. e) dilator of compatible size. f) scalpel. g) adhesive dressing. 6) sterile pyrogen free. 7) long expiry. [ai(2025-26) , item code no.s-67009, sl. no.2243] ]
Tender For supply of 14656 - silicon foleys catheter 2way no.14 [ warranty period: 30 months after the date of delivery ][quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ]
Tender For supply of 14136 - foleys catheter no. 16 [ warranty period: 30 months after the date of delivery ][quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ]
Tender For srphc82281210-coronary drug eluting stents (1) single wire technology on cobalt based alloy platform (2) stent with coating of biolinx polymer carrier for active drug zotarolimus shown to be effective in preventing neo-intimal hyperplasia) (3) stent diameter should be from 2.25 mm to 4 mm and length of the stent from 12mm to 38 mm. (4) the strut thickness should be 81 micron or less. (5) stent delivery system should be monorail (single operator exchange or rapid exchange). (6) stent should be compatible with 5fr guiding catheter (7) stent design should be open cell type. (8) stent should be approved by dcgi. the copy of dcgi approval should be enclosed in the tender bid. (9) five years long term efficacy and safety of the stent in terms of target vesselrevascularisation (tvr) and in-situ thrombosis (ist) should be documented / published inpeer reviewed scientific journals.(10) the documents pertaining to the efficacy and safety of the stent should be enclosed for the brand that is offered in the tender bid (11) the manufacturer/supplier should submit proof of supply of the stent to a major government institute.[quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ]
Tender For srphc82281275-des-abbreviated dapt long -coronary drug eluting stents with (1) platinum chromium alloy (2) coating of bioabsorbable polymer carrier for activedrug everolimus shown to be effective in preventing neo-intimal hyperplasia) (3) stent diameter should be from 2.5mm to 4mm. the length of the stent should be from 12mm to 48 mm. (4) the strut thickness should be 91 micron or less. (5) stent delivery system should be monorail (single operator exchange or rapid exchange). (6) stent should be compatible with 5fr guiding catheter (7) stent design should be open cell type. (8) stent should be approved by dcgi. the copy of dcgi approval should be enclosed in the tender bid. (9) the long term efficacy and safety of the stent, the rates of in-stent restenosis (isr) and in-situ thrombosis (ist) should be documented / published in peer reviewed scientific journals. (10) safety of abbreviated (three month) dual antiplatelet therapy for high bleeding risk patients should be documented in peer reviewed journals. (11) the manufacturer/supplier should submit proof of supply of the stent to a major government institute. bis standards for the drug eluting stent are not available. (reference:bis catalogue ).[quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ]
Tender For srphc82281225-coronary drug eluting stents with (1) cobalt chromium alloy (2) coating of bioabsorbable polymer carrier with abluminal and gradient coating foractive drug shown to be effective in preventing neo-intimal hyperplasia) (3) stent diameter should be from 2.5mm to 4mm . the length of the stent should be from 12mm to 38 mm. (4) the strut thickness should be 91 micron or less. (5) stent delivery system should bemonorail (single operator exchange or rapid exchange). (6) stent should be compatible with 5fr guiding catheter (7) stent design should be open cell type. (8) stent should be approved by dcgi. the copy of dcgi approval should be enclosed in the tender bid. (9) the long term efficacy and safety of the stent, the rates of in-stent restenosis (isr) and in-situ thrombosis (ist) should be documented / published in peer reviewed scientific journals. (10) safety of abbreviated (one month) dual antiplatelet therapy for high bleedingrisk patients should be documented in peer reviewed journals. (11) the manufacturer/supplier should submit proof of supply of the stent to a major government institute. bis standards for the drug eluting stent are not available. (reference:bis catalogue ).[quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ]
Tender For srphc82281280-des-pt/cr : coronary drug eluting stents (1) on platinum chromium platform (2) stent with coating of polymer carrier for active drug everolimus shown to be effective in preventing neo-intimal hyperplasia) (3) stent diameter shouldbe from 2.5mm to 4mm and length of the stent from 12mm to 38 mm. (4) the strutthickness should be 91 micron or less. (5) stent delivery system should be monorail (single operator exchange or rapid exchange). (6) stent should be compatible with 5fr guiding catheter (7) stent design should be open cell type. (8) stent should be approved bydcgi . the copy of dcgi approval should be enclosed in the tender bid. (9) the long termefficacy and safety of the stent in terms of target vessel revascularisation (tvr) and in-situ thrombosis (ist) should be documented / published in peer reviewed scientific journals.(10) the documents pertaining to the efficacy and safety of the stent should be enclosed for the brand that is offered in the tender bid (11) the manufacturer/supplier should submit proof of supply of the stent to a major government institute.[quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ]